CN108853380B - 治疗糖尿病的药物组合物及其制备方法和应用 - Google Patents
治疗糖尿病的药物组合物及其制备方法和应用 Download PDFInfo
- Publication number
- CN108853380B CN108853380B CN201811143250.5A CN201811143250A CN108853380B CN 108853380 B CN108853380 B CN 108853380B CN 201811143250 A CN201811143250 A CN 201811143250A CN 108853380 B CN108853380 B CN 108853380B
- Authority
- CN
- China
- Prior art keywords
- parts
- pharmaceutical composition
- diabetes
- tea
- root
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 39
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 22
- 238000002360 preparation method Methods 0.000 title abstract description 6
- 239000003814 drug Substances 0.000 claims abstract description 36
- 244000269722 Thea sinensis Species 0.000 claims abstract description 24
- 229910052602 gypsum Inorganic materials 0.000 claims abstract description 16
- 239000010440 gypsum Substances 0.000 claims abstract description 16
- 240000000249 Morus alba Species 0.000 claims abstract description 15
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 15
- 244000061456 Solanum tuberosum Species 0.000 claims abstract description 15
- 235000002595 Solanum tuberosum Nutrition 0.000 claims abstract description 15
- 241000132012 Atractylodes Species 0.000 claims abstract description 14
- 244000302512 Momordica charantia Species 0.000 claims abstract description 14
- 235000009811 Momordica charantia Nutrition 0.000 claims abstract description 14
- 241000405414 Rehmannia Species 0.000 claims abstract description 14
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 claims abstract description 13
- 235000003097 Artemisia absinthium Nutrition 0.000 claims abstract description 13
- 240000001851 Artemisia dracunculus Species 0.000 claims abstract description 13
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 claims abstract description 13
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims abstract description 13
- 241000037740 Coptis chinensis Species 0.000 claims abstract description 13
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 13
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 13
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 13
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 13
- 240000004534 Scutellaria baicalensis Species 0.000 claims abstract description 13
- 235000017089 Scutellaria baicalensis Nutrition 0.000 claims abstract description 13
- 239000001138 artemisia absinthium Substances 0.000 claims abstract description 13
- 235000006533 astragalus Nutrition 0.000 claims abstract description 13
- 235000013351 cheese Nutrition 0.000 claims abstract description 13
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims abstract description 13
- 235000015099 wheat brans Nutrition 0.000 claims abstract description 13
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims abstract description 12
- 235000006468 Thea sinensis Nutrition 0.000 claims abstract description 12
- 235000020279 black tea Nutrition 0.000 claims abstract description 12
- 239000002994 raw material Substances 0.000 claims abstract description 12
- 229940087559 grape seed Drugs 0.000 claims abstract description 11
- 241000045403 Astragalus propinquus Species 0.000 claims abstract description 9
- 241001474374 Blennius Species 0.000 claims abstract description 8
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 8
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 8
- 240000006023 Trichosanthes kirilowii Species 0.000 claims abstract description 8
- 235000009818 Trichosanthes kirilowii Nutrition 0.000 claims abstract description 8
- 235000009812 Momordica cochinchinensis Nutrition 0.000 claims abstract description 7
- 235000018365 Momordica dioica Nutrition 0.000 claims abstract description 7
- 239000000203 mixture Substances 0.000 claims abstract description 6
- 241000219991 Lythraceae Species 0.000 claims abstract description 5
- 241000304195 Salvia miltiorrhiza Species 0.000 claims abstract 4
- 239000000463 material Substances 0.000 claims description 18
- 239000000843 powder Substances 0.000 claims description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 235000013616 tea Nutrition 0.000 claims description 12
- 240000004980 Rheum officinale Species 0.000 claims description 11
- 235000008081 Rheum officinale Nutrition 0.000 claims description 11
- 238000000855 fermentation Methods 0.000 claims description 11
- 230000004151 fermentation Effects 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 11
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 10
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 10
- 238000001035 drying Methods 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 235000008322 Trichosanthes cucumerina Nutrition 0.000 claims description 7
- 241000218989 Trichosanthes Species 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 241001633680 Polygonatum odoratum Species 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- 241001061264 Astragalus Species 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- 238000010298 pulverizing process Methods 0.000 claims description 4
- 210000004233 talus Anatomy 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 3
- 235000017803 cinnamon Nutrition 0.000 claims description 3
- 230000000249 desinfective effect Effects 0.000 claims description 3
- 235000019225 fermented tea Nutrition 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 238000007873 sieving Methods 0.000 claims description 3
- 241001655769 Androsace Species 0.000 claims description 2
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract description 54
- 210000004369 blood Anatomy 0.000 abstract description 53
- 230000000694 effects Effects 0.000 abstract description 11
- 210000003734 kidney Anatomy 0.000 abstract description 11
- 210000002216 heart Anatomy 0.000 abstract description 8
- 210000004153 islets of langerhan Anatomy 0.000 abstract description 7
- 230000003213 activating effect Effects 0.000 abstract description 6
- 238000005728 strengthening Methods 0.000 abstract description 6
- 230000002708 enhancing effect Effects 0.000 abstract description 5
- 230000036772 blood pressure Effects 0.000 abstract description 4
- 206010022489 Insulin Resistance Diseases 0.000 abstract description 3
- 230000002608 insulinlike Effects 0.000 abstract description 2
- 238000002626 targeted therapy Methods 0.000 abstract description 2
- 210000000952 spleen Anatomy 0.000 description 23
- 230000006870 function Effects 0.000 description 19
- 210000004185 liver Anatomy 0.000 description 15
- 210000002784 stomach Anatomy 0.000 description 15
- 230000002829 reductive effect Effects 0.000 description 14
- 201000010099 disease Diseases 0.000 description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 13
- 210000004072 lung Anatomy 0.000 description 13
- 235000009508 confectionery Nutrition 0.000 description 10
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 10
- 206010012735 Diarrhoea Diseases 0.000 description 9
- 208000002193 Pain Diseases 0.000 description 9
- 230000007812 deficiency Effects 0.000 description 9
- 230000036407 pain Effects 0.000 description 9
- 230000001737 promoting effect Effects 0.000 description 8
- 244000132619 red sage Species 0.000 description 8
- 235000019658 bitter taste Nutrition 0.000 description 7
- 210000001124 body fluid Anatomy 0.000 description 7
- 239000010839 body fluid Substances 0.000 description 7
- 206010011224 Cough Diseases 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- 206010023126 Jaundice Diseases 0.000 description 6
- 206010042674 Swelling Diseases 0.000 description 6
- 208000001848 dysentery Diseases 0.000 description 6
- 239000008103 glucose Substances 0.000 description 6
- 210000000496 pancreas Anatomy 0.000 description 6
- 238000010926 purge Methods 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 5
- 102000004877 Insulin Human genes 0.000 description 5
- 108090001061 Insulin Proteins 0.000 description 5
- 208000022531 anorexia Diseases 0.000 description 5
- 230000002354 daily effect Effects 0.000 description 5
- 206010061428 decreased appetite Diseases 0.000 description 5
- 229940125396 insulin Drugs 0.000 description 5
- 210000002700 urine Anatomy 0.000 description 5
- 206010037660 Pyrexia Diseases 0.000 description 4
- 208000031971 Yin Deficiency Diseases 0.000 description 4
- 210000003743 erythrocyte Anatomy 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 4
- 229960003105 metformin Drugs 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 235000019640 taste Nutrition 0.000 description 4
- 230000035922 thirst Effects 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 208000004998 Abdominal Pain Diseases 0.000 description 3
- 206010000060 Abdominal distension Diseases 0.000 description 3
- 206010000242 Abortion threatened Diseases 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- OEIJRRGCTVHYTH-UHFFFAOYSA-N Favan-3-ol Chemical compound OC1CC2=CC=CC=C2OC1C1=CC=CC=C1 OEIJRRGCTVHYTH-UHFFFAOYSA-N 0.000 description 3
- CITFYDYEWQIEPX-UHFFFAOYSA-N Flavanol Natural products O1C2=CC(OCC=C(C)C)=CC(O)=C2C(=O)C(O)C1C1=CC=C(O)C=C1 CITFYDYEWQIEPX-UHFFFAOYSA-N 0.000 description 3
- 208000034507 Haematemesis Diseases 0.000 description 3
- 241000756042 Polygonatum Species 0.000 description 3
- 208000005985 Threatened Abortion Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 206010000210 abortion Diseases 0.000 description 3
- 231100000176 abortion Toxicity 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 230000004064 dysfunction Effects 0.000 description 3
- 235000011987 flavanols Nutrition 0.000 description 3
- 150000007946 flavonol Chemical class 0.000 description 3
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 3
- 235000011957 flavonols Nutrition 0.000 description 3
- 210000000232 gallbladder Anatomy 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 230000003908 liver function Effects 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 206010036067 polydipsia Diseases 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 230000010415 tropism Effects 0.000 description 3
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 241000723347 Cinnamomum Species 0.000 description 2
- 206010010071 Coma Diseases 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 241000233779 Cyclocarya paliurus Species 0.000 description 2
- 241001523681 Dendrobium Species 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 235000008737 Polygonatum biflorum Nutrition 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 241000219061 Rheum Species 0.000 description 2
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 2
- 240000007164 Salvia officinalis Species 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 206010041497 Spermatorrhoea Diseases 0.000 description 2
- 235000009754 Vitis X bourquina Nutrition 0.000 description 2
- 235000012333 Vitis X labruscana Nutrition 0.000 description 2
- 240000006365 Vitis vinifera Species 0.000 description 2
- 235000014787 Vitis vinifera Nutrition 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 208000031975 Yang Deficiency Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 235000010208 anthocyanin Nutrition 0.000 description 2
- 229930002877 anthocyanin Natural products 0.000 description 2
- 239000004410 anthocyanin Substances 0.000 description 2
- 150000004636 anthocyanins Chemical class 0.000 description 2
- 229940107666 astragalus root Drugs 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000023555 blood coagulation Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 208000013403 hyperactivity Diseases 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 235000005412 red sage Nutrition 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 238000010025 steaming Methods 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 208000004371 toothache Diseases 0.000 description 2
- 102000016912 Aldehyde Reductase Human genes 0.000 description 1
- 108010053754 Aldehyde reductase Proteins 0.000 description 1
- 206010059245 Angiopathy Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241000218202 Coptis Species 0.000 description 1
- 235000002991 Coptis groenlandica Nutrition 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- 208000001380 Diabetic Ketoacidosis Diseases 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010060820 Joint injury Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 241000632869 Pachira glabra Species 0.000 description 1
- 208000035467 Pancreatic insufficiency Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 206010057071 Rectal tenesmus Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 241000405911 Rehmannia glutinosa Species 0.000 description 1
- 206010061481 Renal injury Diseases 0.000 description 1
- 206010038776 Retching Diseases 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 241000593989 Scardinius erythrophthalmus Species 0.000 description 1
- 241000207929 Scutellaria Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 229930014669 anthocyanidin Natural products 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- 150000001453 anthocyanidins Chemical class 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 208000027503 bloody stool Diseases 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000005800 cardiovascular problem Effects 0.000 description 1
- 235000006214 castanha do maranho Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 238000007596 consolidation process Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 235000004879 dioscorea Nutrition 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- LXBIFEVIBLOUGU-JGWLITMVSA-N duvoglustat Chemical compound OC[C@H]1NC[C@H](O)[C@@H](O)[C@@H]1O LXBIFEVIBLOUGU-JGWLITMVSA-N 0.000 description 1
- 210000000613 ear canal Anatomy 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 208000037806 kidney injury Diseases 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 208000006443 lactic acidosis Diseases 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000005976 liver dysfunction Effects 0.000 description 1
- 210000002189 macula lutea Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000008816 organ damage Effects 0.000 description 1
- 235000020830 overeating Nutrition 0.000 description 1
- 230000004203 pancreatic function Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000001235 sensitizing effect Effects 0.000 description 1
- 230000036578 sleeping time Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 208000012271 tenesmus Diseases 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8984—Dendrobium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗糖尿病的药物组合物及其制备方法和应用,该药物组合物包括按重量份计的以下原料:黄芪3‑5份,丹参2‑2.5份,地黄1‑2份,苦瓜2‑3份,玉竹1‑2份,黄连2‑3份,白术0.5‑1份,黄精0.8‑1.5份,黄芩0.5‑1份,天花粉2‑3份,生石膏1.5‑3份,桑根2‑3.5份,石斛2‑3.5份,山药2‑4份,茵陈1‑2份,摇钱树叶2份,桂皮1‑2份,黑茶2‑3份,土豆干3‑5份,葡萄籽1.5‑2份,干酪1‑1.5份,麦麸2‑3份,海藻2‑2.5份。本发明药物组合物通过健肾增抗、活络补心、降压祛脂来控制并发症;通过平衡寒热、通中和体、补气养血来平衡体质;通过输入活性因子、加强类胰岛素因子、提高胰岛素敏感性来进行修复胰岛功能的靶向治疗;能够有效治疗糖尿病,且疗效显著。
Description
技术领域
本发明属于药物组合物技术领域,具体涉及一种治疗糖尿病的药物组合物及其制备方法和应用。
背景技术
西医所谓糖尿病(中医消渴症)需终生服西药,不能治愈。从中医角度来说,该病并非“血、尿”出现问题,而针对血糖(或尿糖)降糖,治标不治本,与其病源、病根风牛马不相及。
“高血糖”并非体内糖超标,而恰恰相反,患者的器官缺糖,这是因为人体所摄入的糖分难以进入血红细胞而不能向肌体各器官输入糖分和能量,而是将糖撇在红细胞之外的血液中,使得血糖、尿糖日渐升高,而形成了所谓“糖尿病”。但这只能是疾病的内原因,并非病灶所在。也就是说并不是血液本身得了病,也不是泌尿系统患了病,其症结是糖分的吸收上出了问题。
西医学之糖尿病,其病理是胰脏中胰岛细胞分泌胰岛素的功能衰退或不足而不能将糖分推入血红细胞之内,显然这是胰岛功能出了问题。然而西医并没有针对胰脏功能的问题进行治疗,而是一味降糖或人为补充胰岛素,从而人为地加速了胰脏分泌功能丧失,例如双呱等西药的副作用可很快造成消化功能和肝功能障碍,严重导致气血郁滞。气血不通或气血运化能量欠缺必然导致胰脏功能障碍,使得β细胞分泌胰岛素的功能失调,彻底违背了肌体自我修复、自我调节、自我痊愈、自我平衡的自然生命法则,最终导致胰岛功能完全丧失,并造成多器官药原性并发症而提前结束生命。
发明内容
本发明的目的是针对以上问题,提供一种治疗糖尿病的药物组合物及其制备方法和应用,能够有效避免西药治疗的弊端,不会反弹。
为解决上述技术问题,本发明所采用的技术方案是:一种治疗糖尿病的药物组合物,其特征在于,包括按重量份计的以下原料:黄芪3-5份,丹参2-2.5份,地黄1-2份,苦瓜2-3份,玉竹1-2份,黄连2-3份,白术0.5-1份,黄精0.8-1.5份,大黄1-2份、黄芩0.5-1份,天花粉2-3份,生石膏1.5-3份,桑根2-3.5份,石斛2-3.5份,山药2-4份,茵陈1-2份,摇钱树叶2-3份,桂皮1-2份,黑茶2-3份,土豆干3-5份,葡萄籽1.5-2份,干酪1-1.5份,麦麸2-3份,海藻2-2.5份。
优选的配方中,包括按重量份计的以下原料:
黄芪4份,丹参2份,地黄1.3份,苦瓜3份,玉竹1.3份,黄连2份,白术0.7份,黄精1份,大黄1.2份,黄芩0.8份,天花粉2份,生石膏1.5份,桑根2.3份,石斛2.8份,山药3.8份,茵陈1.6份,摇钱树叶3份,桂皮1.6份,黑茶2份,土豆干3.8份,葡萄籽1.5份,干酪1.5份,麦麸2.5份,海藻2.1份。
本发明还涉及制备所述治疗糖尿病的药物组合物的方法,
1)根据配方组织原料药材,烘干消毒;
2)将黄芪、丹参、地黄、苦瓜、玉竹、黄连、白术、黄精、大黄、黄芩、天花粉、桑根、石斛、山药、茵陈、黑茶、麦麸和海藻根据比例配伍粉碎,然后加入酵母进行发酵,发酵后的物料取70wt%进行水煎,剩下的物料进行细磨成粉,水煎后的料液过滤,去除滤渣,滤液与细磨成粉的物料合并,再进行浓缩干燥,最后过筛,去筛下物备用;
3)摇钱树叶、桂皮、葡萄籽、干酪、土豆干按比例配伍,然后粉碎,在加入酒精进行提取,再蒸馏去除酒精后得到粉末;
4)生石膏粉碎,并与步骤3)的粉末及步骤2)所得的筛下物进行混合,得到治疗糖尿病的药物组合物。
进一步地,浓缩干燥控制温度在80-100℃,最后将温度升至120℃保持1-2h,至原料药材中的水分在10-12%。浓缩干燥时,采用水浴加热的方式进行蒸发浓缩。
烘干和消毒可以同步进行,烘干时,水分不宜过低,一方面可以较好的保持药材的药性,另一方面,也便于后期的机械粉碎。
进一步地,所述酵母为啤酒酵母,加入量为药材总量的0.3-0.6wt%,发酵的温度为25-35℃,时间为48-72h。通过发酵,相当于二次消毒,更重要的是,通过发酵降解后的药剂利于人体充分吸收,提高药效。
进一步地,所述治疗糖尿病的药物组合物为药粉,采用袋用茶袋进行包装或胶囊包装。采用袋用茶袋进行包装时,每袋内装10-15g。
具体服用时,每日2-4次,每次10-15g,开水送服,3个月为一个疗程。也可代茶饮用(茶饮每日10-15g )。
本发明还涉及所述的药物组合物在制备治疗糖尿病药物中的应用。
本发明中使用的原料的性味归经及功能主治如下:
黄芪:性味:甘,微温。归经:归肺、脾、肝、肾经。其有增强机体免疫功能、保肝、利尿、抗衰老、抗应激、降压和较广泛的抗菌作用。
丹参:性味,味苦,微寒。归经:归心、肝经。活血祛瘀,通经止痛,清心除烦,凉血消痈。用于胸痹心痛,脘腹胁痛,瘕瘕积聚,热痹疼痛,心烦不眠,月经不调,痛经经闭,疮疡肿痛。
地黄:所用的地黄为熟地黄,甘,微温。入肝、肾经。滋阴,补血。治阴虚血少,腰膝痿弱,劳嗽骨蒸,遗精,崩漏,月经不调,消渴,溲数,耳聋,目昏。
苦瓜:味苦,性寒。归心、脾、肺经。祛暑涤热,明目,解毒。暑热烦渴,消渴,赤眼疼痛,痢疾,疮痈肿毒。
玉竹:性平,味甘,养阴润燥,生津止渴。用于肺胃阴伤,燥热咳嗽,咽干口渴,内热消渴。
黄连:味苦,性寒。归心、脾、胃、肝、胆、大肠经。清热燥湿,泻火解毒。主治湿热痞满,呕吐吞酸,泻痢,黄疸,高热神昏,心火亢盛,心烦不寐,心悸不宁,血热吐衄,目赤,牙痛,消渴,痈肿疗疮;外治湿疹,湿疮,耳道流脓。
白术:味苦,甘,性温。归脾、胃经。健脾益气,燥湿利水,止汗,安胎。用于脾虚食少,腹胀泄泻,痰饮眩悸,水肿,自汗,胎动不安。土白术健脾,和胃,安胎。用于脾虚食少,泄泻便溏,胎动不安。
黄精:具有补脾,润肺生津的作用。
大黄:苦,寒。入胃、大肠、肝经。泻热毒,破积滞,行瘀血。治实热便秘,谵语发托,食积痞满,痢疾初起,里急后重,瘀停经闭,症瘕积聚,时行热疫,暴眼赤痛,吐血,衄血,阳黄,水肿,淋浊,溲亦,痈疡肿毒,疔疮,汤火伤。泻热通肠,凉血解毒,逐瘀通经。用于实热便秘、积滞腹痛、泻痢不爽、湿热黄疸。
黄芩:味苦,性寒。归肺、胆、脾、大肠、小肠经。清热燥湿,泻火解毒,止血,安胎。用于湿温、暑湿,胸闷呕恶,湿热痞满,泻痢,黄疸,肺热咳嗽,高热烦渴,血热吐衄,痈肿疮毒,胎动不安。
天花粉:甘、微苦,微寒。归肺、胃经。清热泻火,生津止渴,消肿排脓。热病烦渴,肺热燥咳,内热消渴,疮疡肿毒。
生石膏:辛、甘,微寒。归肺、胃经。清热泻火药。
桑根:味微苦,性寒性。归肝经。清热定惊,祛风通络。用于惊痫,目赤,牙痛,筋骨疼痛。
石斛:味甘,性微寒。归胃、肾经。益胃生津,滋阴清热。用于热病津伤,口干烦渴,胃阴不足,食少干呕,病后虚热不退,阴虚火旺,骨蒸劳热,目暗不明,筋骨痿软。
山药:甘,平。入肺、脾、肾经。健脾,补肺,固肾,益精。治脾虚泄泻,久痢,虚劳咳嗽,消渴,遗精、带下,小便频数。补脾养胃,生津益肺,补肾涩精。用于脾虚食少、久泻不止、肺虚喘咳、肾虚遗精、带下、尿频、虚热消渴。麸炒山药补脾健胃。用于脾虚食少,泄泻便溏,白带过多。
茵陈:味苦、辛,性微寒。归脾、胃、肝、胆经。有清利湿热,利胆退黄的功效。用于黄疸尿少,湿温暑湿,湿疮瘙痒
摇钱树叶:味微苦,性温。味微苦,性温。祛风,消炎止痛,杀虫,止痒。
桂皮:味辛、甘,性温。归脾、胃、肝、肾经。温中散寒,理气止痛。用于脘腹冷痛,呕吐泄泻,腰膝酸冷,寒疝腹痛,寒湿痹痛,瘀滞痛经,血痢,肠风,跌打肿痛,创伤出血等。
黑茶:富含黄烷醇、黄酮醇、花青素等抗氧化物质。
土豆干:土豆干的具体制备方法是将土豆切片晾干。入药时进行粉碎。
本发明采取易医中草药的根治方法,从以下三个方面同时入手进行治疗。
其一,控制并发症或预防并发症。并发症主要有急性和慢性两大类。按西医说法,急性并发症有“糖尿病酮症酸中毒”及“乳酸酸中毒”和“高渗非酮症昏迷”,其危害较大,甚至可危及到生命。慢性并发症几乎殃及到人体各个组织器官,如肾损伤、大血管病变、心、脑、肝、下肢血管病变、眼底黄斑、关节损伤等等。最至命的是肾、心脑血管及下肢血管病变。本发明中控制和预防原则是,活络通微,益气养血,温阳化瘀,加强气血循环和肌体抗氧化能力;同时疏肝降脂,清热养阴、软脉降压、补固肾精等。其对应药材为黄芪、丹参、地黄、苦瓜、玉竹、黄连和白术等。
其二,平衡体质,强化肌体自调自愈本能。糖尿病患者患病之前均显体质偏颇,抗体渐衰。病因多为饮食无节,过食肥甘,导致内热伤津,气机不运和肝脾不合,至使瘀滞腹满,脾胃积湿,中焦失阳,从而气机瘀阻。显然,阴虚燥热为标为假象(特别是病初),实则阳虚为本为根。如以“阴虚燥热”的假象进行施治必将滋阴而以阴抑阳,形成对抗而伤及阴阳互根运作机制,必然导致上热下寒,寒热错杂,虚实并见,中焦失律。进而形成热不温肾,肾虚阳衰,寒凝血结之证。从而肝(血糖恒定之源)、脾(血液生化之源)、胰(津液生化之源)无有能量(缺糖)推动气血,消化功能和肝功能进一步郁滞而更难以进行糖的吸收、转化、分解;由此糖分子聚积而使其分子颗粒增大而无力进入红细胞,血糖日高。
综上所述,“中焦受阻”为体质偏颇之所在,为此重在调治和疏导肝、脾、胰之运化功能,以使之“三才交泰,通中和体”。其方剂组合之一遵循“辛开苦降”之法,药材为:黄精、大黄、黄芪、黄芩、天花粉、生石膏、桑根、石斛、山药、茵陈等。
其三,靶向功坚,修复胰岛功能。在上述控制并发症(宏观调阳)和平衡体质(整体养阴),且促使二者互调互根为平衡要求的生命“生生重演”基础上进行功坚,修复已被削弱或丧失了的胰岛功能。这一点至关重要,也就是说没有生理上的生命因子(被伤害的细胞等)的复活及其经络运行能量的恢复和整体体质上的平衡及其平衡机制的回归和正气的充盈,修复胰岛及其功能是绝对不可能的。这便是彻底根治糖尿病的关键所在。修复胰岛功能简约的讲就是修复已被伤害的胰脏及其胰岛的化糖功能。修复胰脏及其胰岛功能重在补其胰脏缺失和促其代谢功能的恢复和强化。与其同时还必须化强肝功能(因为肝瘀引影血糖值的安定)。
本发明的配方中,通过药物组合物提供蛋白酶(来源于摇钱树叶可促其代谢)、茶多酚(来源于黑茶、摇钱树叶。富含黄烷醇、黄酮醇、花青素等抗氧化物质)、茶多糖(来源于黑茶。可降血脂、抗血凝、抗血栓、抗氧化,启动并激活胰岛素之分泌,抗氧化)、花青素(来源于葡萄籽等。含丰富的黄烷醇、黄酮醇,可增强血管弹性,打通微循环,开启疏糖通导,强化抗氧化能力)、硫辛酸可强化肝功能,阻止蛋白质糖基化,抑制醛糖还原酶,阻止糖尿增进,促使葡萄糖利用,抗糖化以安定血糖值。抗氧化,抗自由基,防并发症、抗细胞衰老)、铬元素(来源于啤酒酵母、干酪、麦麸、海藻,是葡萄糖耐量因子的重要组成成分,参与血糖的化调,对高血糖引起的心血管病变具极好的防治作用。同时可降低胆固醇,降低动脉硬化等心血管问题所引起的风险)、天然类胰岛素(来源于桂皮,对胰岛功能的恢复至关重要)、1一脱氧野尻霉素(DNJ)(来源于桑根,可显著缓解多糖的降解过程,降低餐后血糖峰值、稳定空腹血糖,还有胰岛素增敏作用,改善胰岛素抵抗)等等。
本发明药物组合物通过健肾增抗、活络补心、降压祛脂来控制并发症;通过平衡寒热、通中和体、补气养血来平衡体质;通过输入活性因子、加强类胰岛素因子、提高胰岛素敏感性来进行修复胰岛功能的靶向治疗;能够有效治疗糖尿病,且疗效显著,无副作用,已治愈了近千计患者,轻者1-2疗程痊愈,重者2-6疗程痊愈,终生停药。对于糖尿病初中期的患者,治愈率可以达到98%,晚期患者的治愈率可以达到88%,多脏器受损并发症严重者可辅助胰岛功能而延长寿命。
具体实施方式
下面结合实施例,进一步阐明本发明。
实施例1:
一种治疗糖尿病的药物组合物,包括按重量份计的以下原料:黄芪3份,丹参2份,地黄1份,苦瓜2份,玉竹1份,黄连2份,白术0.5份,黄精0.8份,大黄1份,黄芩0.5份,天花粉2份,生石膏1.5份,桑根2份,石斛2份,山药2份,茵陈1份,摇钱树叶2份,桂皮1份,黑茶2份,土豆干4份,葡萄籽1.5份,干酪1份,麦麸2份,海藻2份。
实施例2:
一种治疗糖尿病的药物组合物,包括按重量份计的以下原料:黄芪5份,丹参2.5份,地黄2份,苦瓜3份,玉竹2份,黄连3份,白术1份,黄精1.5份,大黄2份,黄芩1份,天花粉3份,生石膏3份,桑根3.5份,石斛3.5份,山药4份,茵陈2份,摇钱树叶2份,桂皮2份,黑茶3份,土豆干5份,葡萄籽2份,干酪1.5份,麦麸3份,海藻2.5份。
实施例3:
一种治疗糖尿病的药物组合物,包括按重量份计的以下原料:黄芪4份,丹参2.3份,地黄1.5份,苦瓜2.5份,玉竹1.5份,黄连2.5份,白术0.8份,黄精1份,大黄1.5份,黄芩0.8份,天花粉2.5份,生石膏2.5份,桑根3份,石斛3份,山药3份,茵陈1.5份,摇钱树叶2份,桂皮1.5份,黑茶2.5份,土豆干4.5份,葡萄籽1.8份,干酪1.2份,麦麸2.6份,海藻2.3份。
实施例4:
一种治疗糖尿病的药物组合物,包括按重量份计的以下原料:黄芪4份,丹参2份,地黄1.3份,苦瓜3份,玉竹1.3份,黄连2份,白术0.7份,黄精1份,大黄1.2份,黄芩0.8份,天花粉2份,生石膏1.5份,桑根2.3份,石斛2.8份,山药3.8份,茵陈1.6份,摇钱树叶3份,桂皮1.6份,黑茶2份,土豆干3.8份,葡萄籽1.5份,干酪1.5份,麦麸2.5份,海藻2.1份。
上述药物组合物的加工工艺流程如下:
具体包括以下步骤:
1)根据配方组织原料药材,烘干消毒;
2)将黄芪、丹参、地黄、苦瓜、玉竹、黄连、白术、黄精、大黄、黄芩、天花粉、桑根、石斛、山药、茵陈、黑茶、麦麸和海藻根据比例配伍粉碎,然后加入酵母进行发酵,发酵后的物料取70wt%进行水煎,剩下的物料进行细磨成粉,水煎后的料液过滤,去除滤渣,滤液与细磨成粉的物料合并,再进行浓缩干燥,最后过筛,去筛下物备用;
3)将摇钱树叶、桂皮、葡萄籽、干酪、土豆干按比例配伍,然后粉碎,在加入酒精进行提取,再蒸馏去除酒精后得到粉末;
4)将生石膏粉碎,并与步骤3)的粉末及步骤2)所得的筛下物进行混合,得到治疗糖尿病的药物组合物。
浓缩干燥时控制温度在80-100℃,最后将温度升至120℃保持1-2h,至原料药材中的水分在10-12%。
所述酵母为啤酒酵母,加入量为药材总量的0.3-0.6wt%,发酵的温度为25-35℃,时间为48-72h。
所述治疗糖尿病的药物组合物为药粉,采用袋用茶袋进行包装或胶囊包装。
采用袋用茶袋进行包装时,每袋内装10-15g。
服用方法:每日2-4次,每次10-15g药粉,开水送服, 3个月为一疗程。
服药期间注意饮食清单,每日适当运动,确保睡眠时间等,有助于提升药效。
下面提供病例,进一步说明其效果。
病例1:王某某,74岁,患三高15年,血糖值为16mmol/L,2017年10月就诊,开始服用按实施例4配制的药物,服药量为每日2次,每次10g,同时按规定剂量服用二甲双胍;服药2个月后,按实施例4配制的药物保持不变,二甲双胍按规定剂量一半服用;再服药1个月后,血糖值降至10 mmol/L,继续服用按实施例4配制的药物3个月,同时二甲双胍的服用量在前面基础上再减半, 2018年4月,停止服用二甲双胍,继续服用按实施例4配制的药物3个月,血糖降至6 mmol/L,至2018年7月停止服用任何药物。至今监测血糖在正常范围内。
病例2:李某某,60岁,患病10年,2018年2月就诊时血糖为15 mmol/L,服用实施例4配制的药物,第一疗程服药完后,血糖为11 mmol/L,第二疗程服药完后,血糖降至正常范围,目前正在继续服用第三疗程药物予以巩固。服药量为每日3次,每次12g。
病例3:赵某某,55岁,患病6年,于2016年3月就诊,血糖高至18 mmol/L,服用按实施例1配制的药物,服用一个疗程后,血糖降至15 mmol/L,第二疗程后降至7-8 mmol/L,第三疗程后降至6 mmol/L以下,后稍有回升,继续服药2个疗程进行巩固,停药至今未反弹。服药量为每日3-4次,每次服药量为12-15g。
病例4:苏某,48岁,患病6年,于2015年6月就诊,血糖高达18 mmol/L,服用按实施例2配制的药物,第一疗程后降至13 mmol/L,第三疗程后降至正常范围,至今未反弹。服药量为4次/日,每日15g。
病例5:周某,46岁,患病5年,2017年2月就诊,血糖为16 mmol/L,服用按实施例3配制的药物,服药20天血糖降至14 mmol/L,第一疗程之后降至10 mmol/L,第二疗程降至正常。服药量为3次/日,15g/次。
病例6:陈某某,52岁,患病3年,2016年8月就诊,血糖为12 mmol/L,服用按实施例4配制的药物,一个疗程后即降至正常。服药量为2次/日,10g/次。
病例7:陈某某,71岁,患病10年,服用按实施例4配制的药物,3个疗程后血糖降至正常范围。
病例8:吴某某,58岁,就诊时血糖为15 mmol/L,服用本发明的药物3个疗程后血糖降至正常范围。
以上实施例时本发明较佳的实施例,应理解为仅用于说明本发明而不是用于限制本发明的保护范围。在阅读了本发明记载的内容之后,本领域技术人员可以对本发明作各种改动或修改,这些等效变化和修饰同样落入本发明权利要求书所限定的范围。
Claims (8)
1.一种治疗糖尿病的药物组合物,其特征在于,由按重量份计的以下原料制成:黄芪3-5份,丹参2-2.5份,地黄1-2份,苦瓜2-3份,玉竹1-2份,黄连2-3份,白术0.5-1份,黄精0.8-1.5份,大黄1-2份、黄芩0.5-1份,天花粉2-3份,生石膏1.5-3份,桑根2-3.5份,石斛2-3.5份,山药2-4份,茵陈1-2份,摇钱树叶2-3份,桂皮1-2份,黑茶2-3份,土豆干3-5份,葡萄籽1.5-2份,干酪1-1.5份,麦麸2-3份,海藻2-2.5份。
2.根据权利要求1所述的治疗糖尿病的药物组合物,其特征在于:黄芪4份,丹参2份,地黄1.3份,苦瓜3份,玉竹1.3份,黄连2份,白术0.7份,黄精1份,大黄1.2份,黄芩0.8份,天花粉2份,生石膏1.5份,桑根2.3份,石斛2.8份,山药3.8份,茵陈1.6份,摇钱树叶3份,桂皮1.6份,黑茶2份,土豆干3.8份,葡萄籽1.5份,干酪1.5份,麦麸2.5份,海藻2.1份。
3.制备权利要求1或2所述治疗糖尿病的药物组合物的方法,其特征在于:
1)根据配方组织原料药材,烘干消毒;
2)将黄芪、丹参、地黄、苦瓜、玉竹、黄连、白术、黄精、大黄、黄芩、天花粉、桑根、石斛、山药、茵陈、黑茶、麦麸和海藻根据比例配伍粉碎,然后加入酵母进行发酵,发酵后的物料取70wt%进行水煎,剩下的物料进行细磨成粉,水煎后的料液过滤,去除滤渣,滤液与细磨成粉的物料合并,再进行浓缩干燥,最后过筛,去筛下物备用;
3)将摇钱树叶、桂皮、葡萄籽、干酪、土豆干按比例配伍,然后粉碎,在加入酒精进行提取,再蒸馏去除酒精后得到粉末;
4)生石膏粉碎,并与步骤3)的粉末及步骤2)所得的筛下物进行混合,得到治疗糖尿病的药物组合物。
4.根据权利要求3所述的方法,其特征在于:步骤2)浓缩干燥控制温度在80-100℃,最后将温度升至120℃保持1-2h,至原料药材中的水分在10-12%。
5.根据权利要求3所述的方法,其特征在于:所述酵母为啤酒酵母,加入量为药材总量的0.3-0.6wt%,发酵的温度为25-35℃,时间为48-72h。
6.根据权利要求3所述的方法,其特征在于:所述治疗糖尿病的药物组合物为药粉,采用袋用茶袋进行包装或胶囊包装。
7.根据权利要求6所述的方法,其特征在于:采用袋用茶袋进行包装时,每袋内装10-15g。
8.权利要求1或2所述的药物组合物或权利要求3-7任意一项所述方法得到的药物组合物在制备治疗糖尿病药物中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811143250.5A CN108853380B (zh) | 2018-09-28 | 2018-09-28 | 治疗糖尿病的药物组合物及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811143250.5A CN108853380B (zh) | 2018-09-28 | 2018-09-28 | 治疗糖尿病的药物组合物及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108853380A CN108853380A (zh) | 2018-11-23 |
CN108853380B true CN108853380B (zh) | 2021-04-13 |
Family
ID=64324924
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811143250.5A Active CN108853380B (zh) | 2018-09-28 | 2018-09-28 | 治疗糖尿病的药物组合物及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108853380B (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101091765A (zh) * | 2007-06-08 | 2007-12-26 | 余仁生国际有限公司 | 药物组合物及其预防和治疗糖尿病的用途 |
CN105582299A (zh) * | 2016-02-29 | 2016-05-18 | 朱怀安 | 一种治疗糖尿病的中药组合物 |
CN108126161A (zh) * | 2018-02-08 | 2018-06-08 | 周天元 | 一种治疗高血压的中草药及其制备方法和应用 |
CN108126068A (zh) * | 2018-02-08 | 2018-06-08 | 周天元 | 一种治疗骨痹的中草药液及其制备方法和应用 |
CN108434242A (zh) * | 2018-06-22 | 2018-08-24 | 中南民族大学 | 一种用于治疗糖尿病及其并发症的药物组合物、制备方法及其用途 |
-
2018
- 2018-09-28 CN CN201811143250.5A patent/CN108853380B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101091765A (zh) * | 2007-06-08 | 2007-12-26 | 余仁生国际有限公司 | 药物组合物及其预防和治疗糖尿病的用途 |
CN105582299A (zh) * | 2016-02-29 | 2016-05-18 | 朱怀安 | 一种治疗糖尿病的中药组合物 |
CN108126161A (zh) * | 2018-02-08 | 2018-06-08 | 周天元 | 一种治疗高血压的中草药及其制备方法和应用 |
CN108126068A (zh) * | 2018-02-08 | 2018-06-08 | 周天元 | 一种治疗骨痹的中草药液及其制备方法和应用 |
CN108434242A (zh) * | 2018-06-22 | 2018-08-24 | 中南民族大学 | 一种用于治疗糖尿病及其并发症的药物组合物、制备方法及其用途 |
Non-Patent Citations (3)
Title |
---|
中药茵陈治疗2型糖尿病的临床疗效观察;陈启显;《包头医学院学报》;20151231;第31卷(第5期);第98-99页 * |
健脾降糖饮对四氧嘧啶糖尿病大鼠TNFα和GMP-140的影响;孙丰雷等;《中国中医基础医学杂志》;20021231;第8卷(第08期);第23页左栏第2节 * |
孙丰雷等.健脾降糖饮对四氧嘧啶糖尿病大鼠TNFα和GMP-140的影响.《中国中医基础医学杂志》.2002,第8卷(第08期), * |
Also Published As
Publication number | Publication date |
---|---|
CN108853380A (zh) | 2018-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104771725B (zh) | 一种治疗虚寒型糖尿病的药物 | |
CN103989970B (zh) | 一种治疗高血压的中药组合物 | |
CN104147536A (zh) | 一种治疗痔疮的药物组合物及其制备方法 | |
CN105250494A (zh) | 一种改善糖代谢中药配方及制备工艺 | |
CN108853380B (zh) | 治疗糖尿病的药物组合物及其制备方法和应用 | |
CN106377700A (zh) | 一种桑叶苦瓜茶及其制备方法 | |
CN102988747B (zh) | 一种三刺降三高的冲剂及其制备方法 | |
CN107441460A (zh) | 一种用于以畏寒为主症的阳虚体质人群调理的中药方剂 | |
CN105435131A (zh) | 一种治疗慢性心衰的中药组合物及其制备方法 | |
CN105250758A (zh) | 一种治疗糖尿病的中药组合物 | |
CN104825892B (zh) | 一种治疗排卵期出血的中药制剂及其制备方法 | |
CN104940720A (zh) | 一种防治造影剂肾病的中药丸剂及其制备方法 | |
CN103656355B (zh) | 用于治疗猪副伤寒的药物及其制备方法 | |
CN104606538A (zh) | 一种用于预防和治疗糖尿病的中药保健品 | |
CN106138494B (zh) | 一种养肾组合物及其生产方法 | |
CN104815194A (zh) | 一种糖尿病肾病药物的制备方法 | |
CN103735906A (zh) | 一种治疗干性支气管扩张的中药制剂及其制备方法 | |
CN108066735A (zh) | 一种治疗慢性肾炎的中药组合物 | |
CN106389965A (zh) | 一种治疗糖尿病的中药组合物及其制备方法 | |
CN107737292B (zh) | 治疗老年人夜尿症的中药制剂及其制备方法 | |
CN102085274A (zh) | 中药治疗急慢性亚级型白血病的组合及其制备方法 | |
CN106266427A (zh) | 一种治疗肾病的中药药酒及其制备方法 | |
CN106166251A (zh) | 一种用于治疗哮喘的中药制剂及其制备方法 | |
CN105709099A (zh) | 一种缓解鼻息肉症状的滴鼻剂及制法 | |
CN105477384A (zh) | 一种降低血压的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |